Up | AC
Pulmonary-Allergy Drugs Advisory Committee
May 01, 2007
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
FDA Briefing Document (pdf)
FDA Errata (pdf)
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. §552). These redacted portions will appear as white space on the screen or on the printed page.
GlaxoSmithKline Briefing Document (pdf)